• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW, INC. TWINFIX TI 3.5 ULTRABRAID; FASTENER, FIXATION, NONDEGRADABLE, SOFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW, INC. TWINFIX TI 3.5 ULTRABRAID; FASTENER, FIXATION, NONDEGRADABLE, SOFT TISSUE Back to Search Results
Model Number 72200752
Device Problem Insufficient Information (3190)
Patient Problem Wound Dehiscence (1154)
Event Date 05/05/2020
Event Type  Injury  
Event Description
It was reported that after surgery, where a twinfix was implanted, the wound presented dehiscence and exudation.This was treated with debridement and local flap transfer during an additional hospitalization.Patient recovered successfully.All available information has been disclosed.If additional information should become available, a supplemental report will be submitted accordingly.
 
Manufacturer Narrative
H10 h6: one 72200752 twinfix ti 3.5 ultrabraid device used in treatment, was not returned for evaluation.Two complaints were opened.Since two of the same product from different manufacturing lots were used.Due to unavailability, evaluation was limited.Instructions for use provides technique specific instruction.Per instructions for use: ¿it is the surgeon¿s responsibility to be familiar with the appropriate surgical techniques prior to use of this device.Read these instructions completely prior to use.Breakage of suture anchor can occur if predrilling is not performed prior to implantation.Excessive force during insertion can cause failure of the suture anchor or insertion device.If more torque is required to insert the anchor, stop and ensure that the anchor size, drill hole size, and depth are correct for the bone conditions encountered.It may be necessary to reduce the anchor size or increase the drill hole size to achieve optimal insertion force.It is the responsibility of the surgeon to determine the patient's bone condition, appropriately prepare the insertion site, and determine the suitability of the implant for the procedure.¿ complaint history review indicated no similar allegation for the lot number reported.Batch review did not indicate a condition, product or procedure failure that supported the allegation.Instructions for use contains recommendations and precautionary statements for proper use of product.Risk management files contain the reported failure.Root cause related to the manufacture of the device was not confirmed.There is no evidence to suggest a direct link between the products used in treatment and the conditions reported.Product met specifications upon release to distribution.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TWINFIX TI 3.5 ULTRABRAID
Type of Device
FASTENER, FIXATION, NONDEGRADABLE, SOFT TISSUE
Manufacturer (Section D)
SMITH & NEPHEW, INC.
130 forbes blvd.
mansfield MA 02048
MDR Report Key10424787
MDR Text Key203461813
Report Number1219602-2020-01275
Device Sequence Number1
Product Code MBI
UDI-Device Identifier03596010578921
UDI-Public03596010578921
Combination Product (y/n)N
PMA/PMN Number
K972326
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 09/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/19/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/01/2024
Device Model Number72200752
Device Catalogue Number72200752
Device Lot Number2025334
Was Device Available for Evaluation? No
Date Manufacturer Received09/18/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age31 YR
-
-